Macrogenics (NASDAQ:MGNX) reported quarterly earnings of $0.27 per share which beat the analyst consensus estimate of $(0.58) by 146.31 percent. This is a 70 percent decrease over earnings of $0.90 per share from the same period last year. The company reported quarterly sales of $72.839 million which beat the analyst consensus estimate of $14.700 million by 395.50 percent. This is a 34.21 percent decrease over sales of $110.708 million the same period last year.